The total return over the past 12 months is -93.15% vs. +16.94% for the S&P 500. So far it's up -71.82% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (93.15%) | (84.70%) | (69.71%) | N/A | N/A | N/A |
| Total Return CAGR | (93.15%) | (84.70%) | (69.71%) | N/A | N/A | N/A |
| Revenue CAGR | +707.02% | +20.77% | (57.90%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
HCW Biologics Inc. (HCWB)
| Year | Start price | End price | HCWB Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.82 | $1.64 | (71.82%) | +14.51% | (86.33%) |
| 2025 | $107.04 | $5.82 | (94.56%) | +17.72% | (112.28%) |
| 2024 | $295.20 | $107.04 | (63.74%) | +24.89% | (88.63%) |
| 2023 | $459.54 | $295.20 | (35.76%) | +26.19% | (61.95%) |
| 2022 | $556.80 | $459.54 | (17.47%) | (18.17%) | +0.70% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
